Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique

British Journal of Pharmacology

Volumn 126, Issue 3, 1999, Pages 621-626

  Kemp, P A ^a   Gardiner, S M ^a   March, J E ^a   Rubin, P C ^a   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Blood flow; Coloured microspheres; Endothelin 1; Magnesium sulphate

Indexed keywords

ENDOTHELIN 1; MAGNESIUM SULFATE; MICROSPHERE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH BLOOD FLOW;

ADRENAL GLANDS; ANIMALS; BLOOD PRESSURE; BRAIN; CONSCIOUSNESS; CORONARY CIRCULATION; ENDOTHELIN-1; EYE; HEART RATE; HINDLIMB; INTESTINE, SMALL; KIDNEY; MAGNESIUM SULFATE; MALE; MICROSPHERES; MUSCLE, SKELETAL; RATS; RATS, LONG-EVANS; REGIONAL BLOOD FLOW; SKIN; SPLEEN; STOMACH; TESTIS; TONGUE;

EID: 0033023530     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702342     Document Type: Article

References (38)

1. ALLCOCK, G.H., WARNER, T.D. & VANE, J.R. (1995). Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Br. J. Pharmacol., 116, 2482 2486.
2. ALTURA, B.M. & ALTURA, B.T. (1981). Magnesium ions and contraction of vascular smooth muscle. Fed. Proc., 40, 2672-2679.
3. ALTURA, B.M. & TURLAPATY, P.D.M.V. (1982). Withdrawal of magnesium enhances coronary arterial spasms produced by vasoactive agents. Br. J. Pharmacol., 77, 649-659.
4. ALTURA, B.T. & ALTURA. B.M. (1980). Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci. Lett., 20, 323-327.
5. BELFORT, M.A. & MOISE JR K.J. (1992). Effect of magnesium sulphate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study. Am. J. Obstet. Gynecol., 167, 661-666.
6. BROWN, Z.W., AMIT, Z. & WEEKS, J.R. (1976). Simple flow-thru swivel for infusions into unrestrained animals. Pharmacol. Biochem. Behav., 5, 363-365.
7. CHI, O.Z., POLLACK, P. & WEISS, H.R. (1990). Effects of magnesium sulphate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch. Int. Pharmacodyn. Ther., 304, 196-205.
8. DIPETTE, D.J., SIMPSON, K. & GUNTUPALLI, J. (1987). Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state. Magnesium, 6, 136-149.
9. ECLAMPSIA TRIAL COLLABORATIVE GROUP. (1995). Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet, 345, 1455-1463.
10. HAKKINEN, J.P., MILLER, M.W., SMITH, A.H. & KNIGHT, D. (1995). Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc. Res., 29, 74-79.
11. ISHISHE, S., PEGRAM, B.L., YAMAMOTO, J., KITAMURA, Y. & FROHLICH, E.D. (1980). Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am. J. Physiol., 233, H443-H449.
12. G-nitro-L-arginine methyl ester, in conscious rats. Clin. Sci., 85, 175-181.
13. 4 in conscious rats. Br. J. Pharmacol., 111, 325-331.
14. KIMURA, T., YASUE, H., SAKAINO, N., ROKUTANDA, M., JOUGASAKI, M. & ARAKI, H. (1989). Effects ofmagnesium on the tone of isolated human coronary arteries. Circulation, 79, 1118-1124.
15. KOWALLIK, P., SCHULZ, R., GUTH, B.D. & SCHADE, A. (1991). Measurement of regional myocardial blood flow with coloured microspheres. Circulation, 83, 974-982.
16. KUGIYAMA, K., YASUE, H., OKUMURA, K., GOTO, K., MINODA, K., MIYAGI, H., MATSUYAMA, K., KOJIMA, A., KOGA, Y. & TAKAHASHI, M. (1988). Suppression of exercise-induced angina by magnesium sulphate in patients with variant angina. J. Am. Coll. Cardiol., 12, 1177-1183.
17. LAURANT, P., MOUSSARD, C., ALBER, D., HENRY, J.C. & BERTHELOT, A. (1992). In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats. Prostaglandins Leukot. Essent. Fatty Acids, 47, 183-186.
18. LUCAS, M.J., LEVENO, K.J. & CUNNINGHAM, F.G. (1995). A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. New Engl. J. Med., 333, 201-205.
19. MACRAE, I.M., ROBINSON, M.J., GRAHAM, D.I., REID, J.L. & MCCULLOCH, J. (1993). Endothelin-1-induced reductions in cerebral blood flow: Dose dependency, time course, and neuropathological consequences. J. Cereb. Blood Flow Metab., 13, 276-284.
20. MALIK, A.B., KAPLAN, J.E. & SABA, T.M. (1976). Reference sample method for cardiac output and regional blood flow determination in the rat. J. Appl. Physiol., 40, 472-475.
21. 1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo. Br. J. Pharmacol., 121, 595-603.
22. MARICHAL, A., HESS, W. & SCHIEBER, G. (1992). Haemodynamics in patients undergoing coronary artery bypass grafting after magnesium aspartate infusion. Anaesthetist, 41, 752-759.
23. NISHIO, A., GREBREWOLD, A., ALTURA, B.T. & ALTURA, B.M. (1989). Comparative vasodilator effects of magnesium salts on rat mesenteric arterioles and venules. Arch. Int. Pharmacodyn. Ther., 298, 139-163.
24. NOGUERA, M.A. & D'OCON, M.P. (1993). Modulatory role of magnesium on the contractile response of rat aorta to several agonists in normal and calcium-free medium. J. Pharm. Pharmacol., 45, 697-700.
25. PERALES, A.J., TORREGROSA, G., SALOM, J.B., MIRANDA, F.J., ALABADI, J.A., MONLEON, J. & ALBORCH, E. (1991). In vivo and in vitro effects of magnesium sulphate in the cerebrovascular bed of the goat. Am. J. Obstet. Gynecol., 165, 1534-1538.
26. RAM, Z., SADEH, M., SHACKED, I., SAHAR, A. & HADANI, M. (1991). Magnesium sulphate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke, 22, 922-927.
27. SEELIG, J.M., WEI, E.P., KONTOS, H.A., CHOI, S.C. & BECKER, D.P. (1983). Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am. J. Physiol., 245, H22-H26.
28. SIPES, S.L., CHESTNUT, D.H., VINCENT JR R.D., WEINER, C.P., THOMPSON, C.S. & CHATTERJEE, M.S. (1991). Does magnesium sulphate alter the cardiovascular response to vasopressor agents in gravid ewes? Anesthesiology, 75, 1010-1018.
29. SKAJAA, K., FORMAN, A. & ANDERSSON, K.-E. (1990). Effects of magnesium on isolated human foetal and maternal uteroplacental vessels. Acta Physiol. Scand., 139, 551-559.
30. SZABO, C., FARAGO, M., DORA, E., HORVATH, I. & KOVACH, A.G.B. (1991). Endothelium-dependent influence of small changes in extracellular magnesium concentration on tone of feline middle cerebral arteries. Stroke, 22, 785-789.
31. SZABO, C., HARDEBO, J. & SALFORD, L.G. (1992). Role of endothelium in the responses of human intracranial arteries to a slight reduction of extracellular magnesium. Exp. Physiol., 77, 209-211.
32. G-monomethyl-L-arginine on arterial pressure and regional blood flow in anaesthetized rats. J. Cardiovasc. Pharmacol., 20, S 176-S178.
33. THEODORSSON-NORHEIM, E. (1987). Friedman and Quade tests: BASIC computer program to perform non-parametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput. Biol. Med., 17, 85-99.
34. 2+ on endothelin-1 and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J. Cardiovasc. Pharmacol., 23, 1004-1010.
35. WELLERS, D., WOUTERS, L., NIJKAMP, F.P. & WYBREN DE JONG. (1976). Distribution of blood flow supplied by the vertebral artery in rats: Anatomical, functional and pharmacological aspects. Experientia, 32, 85-87.
36. WICKER, P. & TARAZI, R.C. (1982). Coronary blood flow measurements with left atrial injection of microspheres in conscious rats. Cardiovasc. Res., 16, 580 586.
37. WOODS, K.L. (1991). Possible pharmacological actions of magnesium in acute myocardial infarction. Br. J. Clin. Pharmacol., 32, 3-10.
38. WOODS, K.L., FLETCHER, F., ROFFE, C. & HAIDER, Y. (1992). Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester intravenous magnesium intervention trial (LIMIT-2). Lancet, 339, 1553-1558.